Tooth Extraction as a Risk Modifier for MRONJ

confidence: high · 5 sources

⚠
Working research — not a recommendation.

This page records what the evidence says a policy does, not what anyone should do about it. It has been synthesized from the cited sources but has not been independently reviewed.

What the evidence says

Tooth extraction is the dental event most often tied to MRONJ in patients on antiresorptive drugs. In one review, 52-61% of MRONJ cases reported extraction as the precipitating event. Extraction was also the largest identifiable dental risk factor at 45%, ahead of periodontal disease at 10%. These are associational figures from cross-sectional and descriptive designs. A separate meta-analysis background statement names extraction as a recognized risk context, but it gives no baseline rates for extracted versus non-extracted patients. The sources therefore support the direction of the association more firmly than its size.

The size of the risk depends on the drug, its route, and its timing. After extraction, MRONJ risk is about 0.5% with oral bisphosphonates and about 14.8% with intravenous bisphosphonates, a 30-fold difference. Across cancer patients exposed to bisphosphonates, post-extraction risk ranges from 1.6% to 14.8%, with some studies reporting 51.9%. The sources do not explain that spread. A retrospective cohort tied risk to timing relative to bone-modifying agent (BMA) therapy. No MRONJ occurred after extractions done before BMA started (0/968). Risk was 1.35% (6/445) for extractions during BMA therapy and 5.71% (2/35) for extractions after BMA ended (χ²=27.3, p≈1.2×10⁻⁶). The after-BMA group is small, so its magnitude is imprecise.

Patient and tooth factors also change the risk. Older osteoporotic Korean patients who had an extraction had a six times higher MRONJ risk. Extracting a tooth with pre-existing inflammation was associated with MRONJ, and 90.2% of MRONJ cases had pre-existing inflammation. The sources give no relative risk comparing infected with non-infected teeth. Mandibular extraction was also associated with MRONJ. In a single-center retrospective cohort, mandibular sites made up 58.6% of MRONJ cases but 45.7% of all extractions (p = 0.046). Posterior mandibular sites made up 39.7% of MRONJ cases but 33.6% of all extractions. Anterior maxillary sites made up 8.6% of MRONJ cases but 20.6% of all extractions. The authors describe the contribution of anatomical location as modest and say it precludes site-based risk triage.

Technique and preparation appear in the evidence, but only thinly. In a cohort of 700 patients who had 1,480 extractions using minimally traumatic techniques, no MRONJ was observed. That cohort had no comparison group using standard technique. One source states that extraction cannot be considered the major risk factor, but may be the major triggering event when done without preventive measures. A meta-regression found no measured effect of the percentage of patients undergoing extraction on the vitamin D difference between MRONJ and control groups (all p > 0.05). That finding concerns vitamin D, not MRONJ incidence after extraction.

Where the evidence splits

One review calls extraction "a principal local risk factor" for MRONJ, and the same review says extraction cannot be considered the major risk factor and is the major trigger only when preventive measures are missing. The source ties the difference to preventive measures. The 0/968 pre-BMA result and the 0/1,480 minimally traumatic result fit that framing, but neither is a controlled comparison against standard practice.

Post-extraction MRONJ risk in cancer patients ranges from 1.6% to 51.9%. The sources identify no study design, population, or period that explains the range. The split is unexplained by the sources on this page.

Thresholds and dose-response

Open empirical questions

Findings

Tooth extraction increases MRONJ risk in patients on antiresorptive or antiangiogenic drugs

confidence — direction: highconfidence — magnitude: lowconsensus: settled on direction; the magnitude is contested or unexplained
mechanism
not established in the claims; extraction is described as a local trigger in exposed patients
effect
increases risk. Extraction was the precipitating event in 52-61% of MRONJ cases and 45% of dental risk factors. Post-extraction risk in cancer patients ranges from 1.6% to 51.9%.
conditions / moderators
drug type, route, dose, timing, and preventive measures; the sources do not explain the range

Intravenous bisphosphonates increase post-extraction MRONJ risk relative to oral bisphosphonates

confidence — direction: highconfidence — magnitude: highconsensus: thin; one meta-analysis and one cohort are cited
mechanism
not established in the claims
effect
about 0.5% risk with oral and about 14.8% with intravenous bisphosphonates (30-fold difference)
conditions / moderators
duration of intravenous therapy above 11 months is reported as a risk factor

Extraction timing relative to BMA therapy changes MRONJ incidence

confidence — direction: highconfidence — magnitude: mediumconsensus: thin; a single retrospective cohort
mechanism
not established in the claims
effect
0% (0/968) for extractions before BMA; 1.35% (6/445) during BMA; 5.71% (2/35) after BMA (χ²=27.3, p≈1.2×10⁻⁶)
conditions / moderators
the after-BMA group is small (2 events), so its magnitude is imprecise; the pre-BMA result required adequate healing and follow-up of at least 18 months

Extraction in older osteoporotic patients increases MRONJ risk

confidence — direction: highconfidence — magnitude: highconsensus: thin
mechanism
not established; age as a direct mechanism is not identified
effect
six times higher MRONJ risk in older osteoporotic Korean patients who had an extraction
conditions / moderators
studied in older osteoporotic Korean patients; replication elsewhere is not established

Extraction of teeth with pre-existing infection or inflammation increases MRONJ risk

confidence — direction: highconfidence — magnitude: lowconsensus: thin; leans toward an association
mechanism
not established; the link between inflammation and MRONJ pathogenesis is not demonstrated
effect
increases risk, with no effect size given; 90.2% of MRONJ cases had pre-existing inflammation
conditions / moderators
high-dose BMA for 8 months or more was associated alongside it

Mandibular extraction sites are associated with more MRONJ than their share of extractions, with a modest contribution

confidence — direction: highconfidence — magnitude: mediumconsensus: thin; both sources lean toward higher mandibular risk, with no quantified incidence ratio
mechanism
not established in the claims
effect
mandibular sites were 58.6% of MRONJ cases vs 45.7% of extractions (p = 0.046); posterior mandibular 39.7% vs 33.6%; anterior maxillary 8.6% vs 20.6%
conditions / moderators
single-center retrospective design; the authors state location contributes modestly and does not support site-based triage

Minimally traumatic technique and preventive measures are associated with fewer MRONJ cases after extraction

confidence — direction: mediumconfidence — magnitude: mediumconsensus: thin
mechanism
not established; the claim states only that extraction without preventive measures may be the major trigger
effect
no MRONJ observed in 700 patients with 1,480 extractions using minimally traumatic techniques
conditions / moderators
no comparison group using standard technique; no breakdown by medication type

Extraction rate shows no measured effect on the vitamin D difference between MRONJ and control groups

confidence — direction: highconfidence — magnitude: highconsensus: thin
mechanism
not applicable
effect
no measured effect in meta-regression (p > 0.05)
conditions / moderators
the outcome is the vitamin D effect size, not MRONJ incidence after extraction